Compositions comprising cetirizine and a non beta-2-adrenoreceptor agonist, a beta-2-adrenoreceptor agonist or an anti-inflammatory and the use thereof for the treatment of respiratory disorders
OwnerMalcolm Philip Young, Roy Druckerinventors
Life of this patent
Estimating the term…
Abstract
There is described a pharmaceutical composition comprising a therapeutically effective amount of cetirizine, or a pharmaceutically acceptable derivative thereof, and a therapeutically effective amount of one or more compounds selected from the group consisting of a non beta-2-adrenoreceptor agonist; a beta-2-adrenoreceptor agonist and an anti-inflammatory agent; in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier.
Claims40
A pharmaceutical composition comprising a therapeutically effective amount of cetirizine, or a pharmaceutically acceptable derivative thereof, and a therapeutically effective amount of one or more compounds selected from the group consisting of a non beta-2-adrenoreceptor agonist;
- a beta-2-adrenoreceptor agonist and an anti-inflammatory agent;
- in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
18-39. (canceled)
A method of treatment of a patient suffering from a respiratory disorder, said method comprising the administration of a therapeutically effective amount of a combination therapy comprising cetirizine, or a pharmaceutically acceptable derivative thereof, and one or more compounds selected from the group comprising a non beta-2-adrenoreceptor agonist;
- a beta-2-adrenoreceptor agonist and an anti-inflammatory agent.
(canceled)
46-48. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Cetirizine, or a pharmaceutically acceptable derivative thereof, and one or more of a non beta-2-adrenoreceptor agonists;
- a beta-2-adrenoreceptor agonists and an anti-inflammatory agents;
- as a combination therapy for administration simultaneously, sequentially or separately, for the treatment or alleviation of a respiratory disorder.
Mefenamic acid as a combination therapy for administration simultaneously, sequentially or separately, with cetirizine, or a pharmaceutically acceptable derivative thereof, for the treatment or alleviation of a respiratory disorder.
(canceled)
Dependencies are inferred from the claim text.